Shanghai STVC Group logo

Shanghai STVC Group

Asia, Shanghai, China, Shanghai

Description

Shanghai STVC Group is an investment Firm.

Investor Profile

Shanghai STVC Group has made 4 investments, with 2 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (25%)
  • Series C (25%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Semiconductor
  • Software
  • Information Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shanghai STVC Group frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 2
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 1
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
CSPC Pharmaceutical Group
Asia, Hebei, China, Shijiazhuang
Co-Investments: 1
Atlas Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
Warburg Pincus
Europe, Madrid, Spain, Boadilla Del Monte
Co-Investments: 1
Chaos Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by Shanghai STVC Group?

Photoacoustic Pharmaceuticals

Pudong, Shandong, China

Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products.

BiopharmaBiotechnologyMedical
Series ANov 26, 2024
Prospective Innovation Institute

Minhang, Shanghai, China

The Prospective Innovation Institute is a technological achievement transformation service provider

Information ServicesService Industry
Series UnknownAug 2, 2024
Amount Raised: $698,402
Enflame

Shanghai, Shanghai, China

Enflame is an artificial intelligence start-up developing cloud-based deep learning chips for AI training platforms.

Artificial Intelligence (AI)Machine LearningSemiconductorSoftware
Series CAug 10, 2022
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942